Minority K65R Variants and Early Failure of Antiretroviral Therapy in HIV-1–infected Eritrean Immigrant

Vineeta Bansal,Karin J Metzner,Huldrych F Günthard,Jürg Böni,Barbara Niederöst,Jan S Fehr,Christine Leemann

doi:10.3201/eid1710.110592

Abstract

Minority K65R Variants and Early Failure of Antiretroviral Therapy in HIV-1–infected Eritrean Immigrant

Highlights

Migrant Health Section Health Protection Agency, Centre for Infections, London, UK, for providing laboratory notification data; and Animal Health, Department for Environment, Food and Rural Affairs, Worcester, UK, for providing pig-holding registrations
The article is dedicated to the memory of Carole Fitzsimons, who was instrumental in planning this study and collecting the worms, but who died before the project was complete
To the Editor: Genotypic drug resistance testing before initiation of first-line antiretroviral therapy (ART) is recommended to detect drug-resistant viruses and to avoid treatment failure caused by preexisting drug-resistant viruses (1)

Summary

Introduction

J.R. Stothard); and University of Copenhagen, Copenhagen, Denmark 8. Nejsum P, Bertelsen MF, Betson M, Stothard JR, Murrell KD. 9. Peng W, Yuan K, Hu M, Zhou X, Gasser RB.

Objectives

Results

Conclusion